NEI Research News

A small pilot clinical study at the National Eye Institute (NEI) suggests that the drug nitisinone increases melanin production in some people with oculocutaneous albinism type 1B (OCA-1B), a rare genetic disease that causes pale skin and hair and poor vi

Neurons somehow know which of their neighbors to connect with and which to avoid in the crowded environment of the central nervous system. But how?

Robert Nussenblatt, M.D., chief of the Laboratory of Immunology at the National Eye Institute (NEI), died on April 17 at age 67.

Scientists from the Medical College of Georgia at Augusta University have discovered that removing a pro-inflammatory enzyme promotes regeneration after an injury to the optic nerve.

National Eye Institute scientists led a collaborative study and zeroed in on genes associated with age-related macular degeneration (AMD), a leading cause of vision loss and blindness among people age 65 and older.

A wearable brain-based device called NGoggle that incorporates virtual reality could help improve glaucoma diagnosis and prevent vision loss.

IUPUI scientists have used retinal ganglion cells derived from human pluripotent stem cells to create models that better mimic the human retina.

A team of researchers has discovered how the brain uses tiny, unconscious eye movements to pick up differences in brightness, likely by “refreshing” signals hitting the retina.

A signaling pathway controlled by transforming growth factor β (TGF-β) could be involved in the progression of age-related macular degeneration (AMD).

“Our data suggest that the two eyes are merged as they arrive in the neocortex and not at a later stage of brain processing, as previously believed,” said Vanderbilt’s Alexander Maier, assistant professor of psychology.